Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Rises By 42.2%

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 6,335 shares, a growth of 42.2% from the December 31st total of 4,455 shares. Currently, 2.6% of the company’s shares are short sold. Based on an average trading volume of 4,774 shares, the days-to-cover ratio is presently 1.3 days. Based on an average trading volume of 4,774 shares, the days-to-cover ratio is presently 1.3 days. Currently, 2.6% of the company’s shares are short sold.

iShares Health Innovation Active ETF Price Performance

BMED opened at $31.08 on Friday. The stock’s 50 day simple moving average is $30.82 and its 200 day simple moving average is $28.22. The firm has a market cap of $7.46 million, a price-to-earnings ratio of 24.91 and a beta of 0.84. iShares Health Innovation Active ETF has a 1 year low of $20.57 and a 1 year high of $32.19.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.